| Medz95 vs Jin | 24–35 | 40.68% |
| Medz95 vs Kazuya | 22–23 | 48.89% |
| Medz95 vs Reina | 22–20 | 52.38% |
| Medz95 vs Steve | 17–22 | 43.59% |
| Medz95 vs Law | 17–21 | 44.74% |
| Medz95 vs King | 15–20 | 42.86% |
| Medz95 vs Eddy | 13–18 | 41.94% |
| Medz95 vs Yoshimitsu | 16–13 | 55.17% |
| Medz95 vs Azucena | 12–16 | 42.86% |
| Medz95 vs Bryan | 4–22 | 15.38% |
| Medz95 vs Lili | 11–15 | 42.31% |
| Medz95 vs Hwoarang | 14–9 | 60.87% |
| Medz95 vs Nina | 8–12 | 40.00% |
| Medz95 vs Asuka | 13–6 | 68.42% |
| Medz95 vs Feng | 4–15 | 21.05% |
| Medz95 vs Alisa | 9–10 | 47.37% |
| Medz95 vs Paul | 9–9 | 50.00% |
| Medz95 vs Dragunov | 5–12 | 29.41% |
| Medz95 vs Victor | 8–9 | 47.06% |
| Medz95 vs Xiaoyu | 7–9 | 43.75% |
| Medz95 vs Lars | 7–7 | 50.00% |
| Medz95 vs Lee | 8–6 | 57.14% |
| Medz95 vs Leo | 5–8 | 38.46% |
| Medz95 vs Jack-8 | 5–7 | 41.67% |
| Medz95 vs Jun | 5–6 | 45.45% |
| Medz95 vs Lidia | 4–5 | 44.44% |
| Medz95 vs Devil Jin | 4–3 | 57.14% |
| Medz95 vs Leroy | 1–4 | 20.00% |
| Medz95 vs Raven | 2–3 | 40.00% |
| Medz95 vs Anna | 2–2 | 50.00% |
| Medz95 vs Claudio | 3–0 | 100.00% |
| Medz95 vs Kuma | 3–0 | 100.00% |
| Medz95 vs Panda | 1–2 | 33.33% |
| Medz95 vs Fahkumram | 1–2 | 33.33% |
| Medz95 vs Shaheen | 0–2 | 0.00% |
| Medz95 vs Zafina | 2–0 | 100.00% |
| Medz95 vs Clive | 2–0 | 100.00% |
| Medz95 vs Heihachi | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.